Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reuben S Harris

Showing results (111-120 of 267) with videos related to

Pageof 27
Sort By:
Biology|May 17, 2014
A Comparison of Two Single-Stranded DNA Binding Models by Mutational Analysis of APOBEC3GKeisuke Shindo, Ming Li, Phillip J Gross, et al.
Methods in Enzymology|October 10, 2024
RADD: A real-time FRET-based biochemical assay for DNA deaminase studiesChristopher A Belica, Patricia C Hernandez, Michael A Carpenter, et al.
FASEB Bioadvances|March 4, 2020
Active site plasticity and possible modes of chemical inhibition of the human DNA deaminase APOBEC3BKe Shi, Özlem Demir, Michael A Carpenter, et al.
Mbio|August 9, 2023
APOBEC3 degradation is the primary function of HIV-1 Vif determining virion infectivity in the myeloid cell line THP-1Terumasa Ikeda, Ryo Shimizu, Hesham Nasser, et al.
The Journal of General Virology|May 31, 2019
HIV-1 restriction by endogenous APOBEC3G in the myeloid cell line THP-1Terumasa Ikeda, Amy M Molan, Matthew C Jarvis, et al.
Oncotarget|November 7, 2015
Degradation of the cancer genomic DNA deaminase APOBEC3B by SIV VifAllison M Land, Jiayi Wang, Emily K Law, et al.
Biorxiv : the Preprint Server for Biology|April 10, 2023
APOBEC3 degradation is the primary function of HIV-1 Vif for virus replication in the myeloid cell line THP-1Terumasa Ikeda, Ryo Shimizu, Hesham Nasser, et al.
Journal of Virology|August 13, 2011
Human and rhesus APOBEC3D, APOBEC3F, APOBEC3G, and APOBEC3H demonstrate a conserved capacity to restrict Vif-deficient HIV-1Judd F Hultquist, Joy A Lengyel, Eric W Refsland, et al.
The Journal of Biological Chemistry|October 26, 2010
A single amino acid in human APOBEC3F alters susceptibility to HIV-1 VifJohn S Albin, Rebecca S LaRue, Jessalyn A Weaver, et al.
Elife|December 2, 2022
Evidence linking APOBEC3B genesis and evolution of innate immune antagonism by gamma-herpesvirus ribonucleotide reductasesSofia N Moraes, Jordan T Becker, Seyed Arad Moghadasi, et al.
Pageof 27

Showing results (111-120 of 267) with videos related to

Sort By:
Pageof 27
Biology|May 17, 2014
A Comparison of Two Single-Stranded DNA Binding Models by Mutational Analysis of APOBEC3GKeisuke Shindo, Ming Li, Phillip J Gross, et al.
Methods in Enzymology|October 10, 2024
RADD: A real-time FRET-based biochemical assay for DNA deaminase studiesChristopher A Belica, Patricia C Hernandez, Michael A Carpenter, et al.
FASEB Bioadvances|March 4, 2020
Active site plasticity and possible modes of chemical inhibition of the human DNA deaminase APOBEC3BKe Shi, Özlem Demir, Michael A Carpenter, et al.
Mbio|August 9, 2023
APOBEC3 degradation is the primary function of HIV-1 Vif determining virion infectivity in the myeloid cell line THP-1Terumasa Ikeda, Ryo Shimizu, Hesham Nasser, et al.
The Journal of General Virology|May 31, 2019
HIV-1 restriction by endogenous APOBEC3G in the myeloid cell line THP-1Terumasa Ikeda, Amy M Molan, Matthew C Jarvis, et al.
Oncotarget|November 7, 2015
Degradation of the cancer genomic DNA deaminase APOBEC3B by SIV VifAllison M Land, Jiayi Wang, Emily K Law, et al.
Biorxiv : the Preprint Server for Biology|April 10, 2023
APOBEC3 degradation is the primary function of HIV-1 Vif for virus replication in the myeloid cell line THP-1Terumasa Ikeda, Ryo Shimizu, Hesham Nasser, et al.
Journal of Virology|August 13, 2011
Human and rhesus APOBEC3D, APOBEC3F, APOBEC3G, and APOBEC3H demonstrate a conserved capacity to restrict Vif-deficient HIV-1Judd F Hultquist, Joy A Lengyel, Eric W Refsland, et al.
The Journal of Biological Chemistry|October 26, 2010
A single amino acid in human APOBEC3F alters susceptibility to HIV-1 VifJohn S Albin, Rebecca S LaRue, Jessalyn A Weaver, et al.
Elife|December 2, 2022
Evidence linking APOBEC3B genesis and evolution of innate immune antagonism by gamma-herpesvirus ribonucleotide reductasesSofia N Moraes, Jordan T Becker, Seyed Arad Moghadasi, et al.
Pageof 27